Generated by AI
SINTX Technologies, Inc. Common Stock represents SINTX Technologies, Inc., an advanced ceramics company focused on silicon nitride–based materials and medical technologies. SINTX develops, manufactures, and commercializes biomaterials, components, and related products for biomedical, technical, and antipathogenic applications. Its portfolio includes solid and porous silicon nitride materials, silicon nitride powders and coatings, composite materials, and finished medical device products used in areas such as spinal, foot and ankle, dental, and joint reconstruction. The company also supports contract manufacturing and other advanced ceramics opportunities, using its materials science platform for both medical and high-value industrial applications. Headquartered in Salt Lake City, Utah, SINTX plays a specialized role in the healthcare materials market by supplying high-performance ceramic solutions designed for durability, biocompatibility, and antimicrobial properties.
Website1885 West 2100 South
Salt Lake City, UT, 84119
United States
The latest articles about SINT.
Two issued patents and three allowed applications support commercialization opportunities in orthopedic devices, biomaterials and medical textiles SALT LAKE CITY, Utah, Nov. 17, 2026 (GLOBE NEWSWIRE) -- SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a global leader in advanced silicon nitride biomaterials and ceramics for medical and industrial applications, today announced two patent issuances and three patent allowances throughout Europe, Canada, Japan and South Korea, adv
SINTX Technologies Inc (SINT) posted record quarterly revenue of $2.2 million, up 953% year-over-year, while narrowing its net loss by 55% and improving gross margins to 62%.
Summary of Oct 1's posts. Generated by AI.
Summary of Oct 21's posts. Generated by AI.
Summary of Sep 3's posts. Generated by AI.
Investors talking about SINT also mention these. Each card shows that asset’s own numbers for the past 24 hours.
Valuation and earnings.